Fritz O.
- Country
- Belgium
- Department
- Hematology
Research Overview
- Phase 1b Study of Loncastuximab Tesirine with Anti-cancer Agents in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- Evaluation of Safety and Pharmacokinetics of Forimtamig in Patients With Relapsed or Refractory Multiple Myeloma
- Phase I Evaluation of ABBV-525, a MALT1 Inhibitor, in Patients with B-Cell Malignancies
Data & Insights
Has run more than one trial at 281 of 468 partner sites.
Specializations
Lymphoma Research
The investigator specializes in treating various forms of lymphoid malignancies, with particular focus on non-Hodgkin lymphoma and its subtypes including mantle cell lymphoma, diffuse large B-cell lymphoma, and follicular lymphoma.
- B-cell non-Hodgkin lymphoma
- Mantle cell lymphoma
- Relapsed/refractory lymphomas
Multiple Myeloma
The investigator has extensive experience in treating multiple myeloma, particularly focusing on relapsed and refractory cases. Their research includes novel therapeutic approaches and combination treatments for this plasma cell disorder.
- Relapsed/refractory multiple myeloma
- Novel therapeutic combinations
- Targeted therapy approaches
Leukemia Studies
The investigator conducts research in chronic lymphocytic leukemia and related conditions, including small lymphocytic lymphoma. Their work encompasses both previously untreated and relapsed/refractory disease states.
- Chronic lymphocytic leukemia
- Small lymphocytic lymphoma
- Richter's syndrome
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.